Preoperative IV dexamethasone to reduce pain after minimally invasive lumbar fusion (MIS-TLIF)
Official title: Efficacy and Safety of Preemptive Intravenous Dexamethasone in MIS-TLIF
Run by Thammasat University Hospital · NCT06367855 · Data updated 2026-11-12
This trial will test whether a single intravenous dose of dexamethasone given before MIS-TLIF reduces postoperative back pain and opioid use in people aged 50–80 having 1–2 level lumbar fusion.
Quick facts
| Phase | Phase 4 |
|---|---|
| Study type | Interventional |
| Ages | 50 Years to 80 Years |
| Sex | All |
| Enrollment | 60 (estimated) |
| Sponsor | Thammasat University Hospital Academic / other |
| Locations | 1 site (Pathum Thani, Changwat Pathum Thani) |
| Status | Recruiting |
| Started | May 1, 2024 |
| Main results expected | November 30, 2025 |
| Study ends | December 31, 2025 |
| Registry record updated | September 8, 2025 |
| Trial ID | NCT06367855 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults 50–80 years old scheduled for 1–2 level MIS-TLIF who have not had prior spine surgery, do not have recent systemic steroid use, and have acceptable glycemic control (HbA1c below 7.5%).
✕Probably not a fit
Patients with prior spine surgery, a history of systemic steroid use, steroid allergy, or poorly controlled diabetes (HbA1c ≥ 7.5%) were excluded and are unlikely to be eligible or benefit from this protocol.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional Phase 4 trial compares a preoperative intravenous dose of dexamethasone with normal saline given before minimally invasive transforaminal lumbar interbody fusion (MIS-TLIF). Participants are patients aged 50–80 undergoing MIS-TLIF at one or two spinal levels and who meet metabolic and medication-related eligibility criteria. Primary outcomes focus on postoperative back pain, with secondary outcomes including opioid (morphine) consumption and other recovery metrics. The design uses a preemptive single injection to test whether adding dexamethasone to standard ERAS medications can further reduce pain and shorten recovery.
Why it matters
Potential benefit: If successful, a single preoperative IV dose of dexamethasone could reduce postoperative back pain, lower opioid requirements, and shorten hospital stay after MIS-TLIF.
How similar studies have gone: Preoperative dexamethasone has demonstrated pain and opioid-sparing benefits in a variety of surgical settings, but evidence specific to preemptive IV use in MIS-TLIF is limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age range: 50-80 years old. * Undergoing MIS TLIF surgery at 1-2 spinal levels. Exclusion Criteria: * Previously undergone spine surgery. * HbA1C greater than or equal to 7.5 mg% * Allergic to all types of experimental medication. * History of using systemic steroids.
Where it's running
-
Thammasat university hospital
Pathum Thani, Changwat Pathum Thani, Thailand Recruiting
Study contacts
- Study coordinator: Konthorn Chankong, Master's degree
- Email: gearkonthorn@gmail.com
- Phone: +66859496902
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Using ZetaFuse Bone Graft to treat cervical disc disease
This study is testing if a new bone graft called ZetaFuse can help people with neck problems feel better and improve their nerve function after surgery.
-
Neuropathic Pain Severity in Lumbar Spinal Stenosis and Its Link to Radiology
This study will test how severe neuropathic pain is in adults with lumbar spinal stenosis and see if it relates to MRI findings and other clinical features.
-
Sarcopenia and Epidural Steroid Injections in Lumbar Spinal Stenosis
We’re testing how sarcopenia relates to pain, function, and quality of life after a routine interlaminar epidural steroid injection in people with lumbar spinal stenosis.
-
Dialogue Support for Lumbar Spine Surgery Decisions
A preoperative visit using a Dialogue Support tool is tested to see if it helps adults planning lumbar spine surgery understand their options and improve outcomes.
-
Correlating periostin levels with spinal degeneration in back pain
This study tests whether periostin levels in the intervertebral disc relate to the severity of disc degeneration in people with chronic low back pain and spinal stenosis.
-
Steroid Injections for Back and Neck Pain: What Works Best
This study tests different steroid injections and combinations to see what provides the best pain relief and function for adults with back or neck pain.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.